Sponsor Pipeline

PrECOG, LLC. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
2
Recruiting
2
Phase 3
4
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-24 NCT03836209
Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia		 Trial completed
Active Trials by Phase
Phase 3
2
Phase 2
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07285239 Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for… Multiple Myeloma Not Yet Recruiting
NCT07637513 Tarlatamab and Durvalumab vs. Durvalumab Alone for Limited-Stage-Small Cell Lung Cancer Limited Stage Small-Cell Lung Cancer Not Yet Recruiting
Phase 2
NCT07057791 Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung… Extensive Stage Lung Small Cell Cancer Recruiting
Not specified
NCT06538038 Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for… Non Small Cell Lung Cancer Recruiting
Disease Areas
Lung Cancer (2) Non-Small Cell Lung Cancer (NSCLC) (1) Small Cell Lung Cancer (1) Multiple Myeloma (1)
Get alerts when PrECOG, LLC.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free